|
|
|
16 June 2017
John Malcolm, Vice President for the Institute for Constitutional Government at The Heritage Foundation, offers his impressions of the nominee for FBI director, Christopher Wray, and discusses the type of relationship that should exist between an FBI director and president, the accountability of the director and James Comey's testimony.
0:00
0:00
Related Podcasts
10 April 2026
Janatan Sayeh, Research Assistant at the Foundation for Defense of Democracies, discusses the state of the Iran war, its future trajectory and wider consequences, and what the two-week ceasefire means and what it may (or may not) accomplish.
30 January 2026
William J. Conti, an attorney from Washington, DC, discusses the first year of President Trump’s second term as president, how it compares to that of other presidents and what it may mean for the 2026 midterm elections.
06 June 2025
Phil Kerpen, President of American Commitment and Principal at the Committee to Unleash Prosperity, discuses the potential victories and disappointments in the current version of President Trump’s “big, beautiful bill,” the players to watch as the bill makes its way through the Senate, the recent analysis from the Congressional Budget Office (CBO), and other administration efforts underway to decrease the deficit and enhance growth.
07 March 2025
William J. Conti, an Attorney from Washington, DC, discusses the winners and losers following President Trump’s address to Congress, the enhanced transparency of the Trump administration, and why the first six weeks of President Trump’s second term look so different from those of his first term.
12 August 2022
William J. Conti, Senior Partner with Baker & Hostetler, discusses key questions and takeaways regarding the FBI's raid on President Donald Trump's home at Mar-a-Lago.
21 December 2017
Sally Pipes, President and CEO and Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute, discusses Alex Azar, President Trump's nomination for secretary of HHS, and what his appointment should mean for free-market healthcare reforms.
